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2To the Editor: Victor Herbert recently discussed the beneficial and harmful aspects of vitamin C
supplementation (1).  In his brief discussion of the possible benefits, he neglected to mention the
effect of vitamin C on the common cold.  Over 20 placebo-controlled studies have consistently
shown that vitamin C (1-6 g/day) alleviates the symptoms of the common cold (2,3).  Most of
these studies were double-blind and the subjects were randomly allocated to the study groups.
Therefore, the observed benefit may reliably be attributed to vitamin C supplementation.  Yet,
there are many other conditions for which vitamin C may be beneficial.  For example, vitamin C
participates in the catabolism of cholesterol to bile acids, and in guinea pigs the reduction of
vitamin C intake causes hypercholesterolemia (4,5).  A number of intervention studies have
found that vitamin C supplementation decreases elevated cholesterol levels in human subjects
(4,5).   None of the intervention studies were referred to by Herbert.
If about 1 g/day of vitamin C were harmful to the general population, this would have been
observed in the numerous epidemiological and interventional studies that have been carried out.
Such doses have not been harmful, but rather they appear to be beneficial (2-7).  Still, even
though 1 g/day of vitamin C is not harmful to the general population, it is possible that such a
dose is harmful to specific subgroups.  In this respect Herbert's comments are valid; he points out
that patients suffering from iron overload may constitute one of these subgroups (1).  However,
the harmful effect of vitamin C on subjects with iron overload and the rationale of treating such
patients with the combination of vitamin C and desferrioxamine have been known for a long
time (8,9).  In healthy subjects, the concentration of free iron ions in plasma is extremely low,
below the detection limit of current methods (10).  Therefore vitamin C in plasma does not
promote the formation of free radicals, but efficiently reacts with radicals formed by other
mechanisms, thereby inhibiting lipid peroxidation and other harmful effects (3,11).
   The effect of vitamin C on iron absorption is not as simple as suggested by Herbert (1).  In
order to quantify the effect of vitamin C supplementation on iron status, Cook et al. administered
2 g/day of the vitamin to 9 subjects for two years.  There were no indications of iron
accumulation (12).  However, this study was not mentioned by Herbert (1).
In addition to the interaction of vitamin C with iron, Herbert presented a list of other
possible harms from vitamin C supplementation (1).  He did not explicitly refer to the original
publications, but took the list from another review (13).  The list contains the claim, originally
made by Herbert himself, that vitamin C causes breakdown of vitamin B12 (14).  However, it was
shown over ten years ago that the reported decrease in vitamin B12 level was due to
methodological shortcomings (15,16), and the vitamin B12 level is not decreased in patients that
have been given as much as 4 g/day of vitamin C (17).
Herbert also claims that vitamin C may cause miscarriages (1,13).  This suggestion is based
on a brief Russian publication from 27 years ago (18).  Twenty women whose menstruation was
delayed by 10-15 days were given 6 g/day of vitamin C, and 16 of them started to menstruate
within 3 days (18).  Pauling wrote a letter to the authors inquiring whether any direct test of
pregnancy was carried out, but as a reply he received only a copy of the publication (7).  Thus,
there is no evidence that the women were pregnant initially; possibly they just had irregular
menstruation.
Five decades ago Levey and Suter reported that vitamin C potentiates the diabetogenic
action of alloxan in rats (19).  Blood sugar level was determined 3 days after injecting alloxan, or
alloxan with vitamin C (0.2 g/kg), to the rats.  Hyperglycemia was observed in 50% of the rats
treated with alloxan and vitamin C, in contrast to 17% of the rats treated with alloxan alone (19).
The authors concluded from their own previous work that "ascorbic acid alone does not produce
hyperglycemia" (19).  This old experiment with alloxan-treated rats is the basis for Herbert's
belief that large doses of vitamin C, alone, may reduce insulin production in human subjects
(1,13).
3Rivers reviewed 74 publications dealing with the proposed toxicity of vitamin C and
concluded that "large quantities of ascorbic acid will not result in calcium-oxalate stones,
increased uric acid excretion, impaired vitamin B12 status, iron overload, systemic conditioning,
or increased mutagenic activity in healthy individuals" (20).  In another review, Marks
concluded that "a large number of adverse reactions have been alleged to occur with the use of
large doses of ascorbic acid, but almost without exception further study has demonstrated that
the allegations are without foundation ... an overview of all the information shows that the safe
daily level is at least 100 times the RDA" (21).  The RDA level for vitamin C is 60 mg/day (22).
Hence, these two reviewers and several others have reached very different conclusions about
vitamin C toxicity when compared to Herbert (1).
Thus, Herbert's conclusions that there are no reliable data to show that vitamin C
supplementation may provide any benefits, and that vitamin C supplements may instead be
highly harmful, are largely based on biased selection of references.
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